$0.91
▲ +$0.01
(+1.00%)
Vol 265K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$67.8M
ROE
-68.5%
Margin
-42171.0%
D/E
2.22
Beta
1.46
52W
$1–$3
Wall Street Consensus
14 analysts · Apr 20264
Strong Buy
7
Buy
3
Hold
0
Sell
0
Strong Sell
78.6%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 60.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.15 | $-0.15 | +$0.00 |
| Sep 2025 | $-0.15 | $-0.18 | $-0.03 |
| Jun 2025 | $-0.19 | $-0.21 | $-0.02 |
| Mar 2025 | $-0.19 | $-0.13 | +$0.06 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $124K | -$423 | — | $39K | $24K |
| Net Income | -$17.4M | -$5.1M | -$8.3M | -$14.4M | -$12.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -71.3% | -71.3% | -71.3% | -71.3% | -68.5% | -68.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -36561.7% | -19522.1% | -19522.1% | -19522.1% | -42171.0% | -42171.0% |
| Gross Margin | -5985.7% | -1325.6% | -1325.6% | -1325.6% | -3693.7% | -3693.7% |
| D/E Ratio | 1.11 | 1.11 | 1.11 | 1.11 | 2.22 | 2.22 |
| Current Ratio | 4.10 | 4.10 | 4.10 | 4.10 | 3.33 | 3.33 |
Key Ratios
ROA (TTM)
-53.2%
P/S (TTM)
912.56
P/B
2.0
EPS (TTM)
$-0.61
CF/Share
$-0.73
52W High
$2.77
52W Low
$0.71
$0.71
52-Week Range
$2.77
Financial Health
Free Cash Flow
-$9.1M
Net Debt
-$5.5M
Cash
$6.4M
Total Debt
$971K
As of Sep 30, 2025
How does IFRX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
IFRX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
912.6
▲
7002%
above
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.0
▼
18%
below
peers
(2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
IFRX profitability vs Biotechnology peers
ROE
-68.5%
▼
2%
below
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-42171.0%
▼
14607%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
-3693.7%
▼
4799%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-53.2%
▼
14%
below
peers
(-46.7%)
vs Peers
vs Industry
In line
IFRX financial health vs Biotechnology peers
D/E ratio
2.2
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
3.3
▼
25%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.5
▲
50%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
IFRX fundamentals radar
IFRX
Peer median
Industry
IFRX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
IFRX vs peers: key metrics
Top Holders
Top 5: 24.65%Suvretta Capital Management…
11.82%
$6.9M
683 Capital Management LLC
4.94%
$2.9M
Bank of America Corporation
3.69%
$2.2M
Eversept Partners, LP
2.62%
$1.5M
Morgan Stanley
1.58%
$927K
As of Dec 31, 2025
Latest News
No related news yet